A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer Interventions: Drug: Capivasertib; Drug: Enzalutamide; Drug: Abiraterone Sponsors: AstraZeneca; Parexel Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials